Kirk Minkus, MD
Vascular & Interventional Radiology · Mesa, AZNPI 1164494746
Payments from drug & device makers
What this record shows
Medtronic accounts for 64.2% of it on its own, with 38 other manufacturers making up the rest. 2025 is the largest year on record at $10,415, 5.0 times the $2,091 reported in 2019.
Across 328 payments — averaging $57.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Philips North America LLC$938
- Siemens Medical Solutions USA, Inc.$801
- Johnson & Johnson$553
- Impulse Dynamics (USA) Inc.$523
- Abbott$491
- plus $3K from 33 others
Across 1 payment — averaging $9750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$10K
What the payments were for
- Travel & lodging$8,91147%
- Food & beverage$9,92953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 95 | $12,092 |
| Philips North America LLC | 22 | $938 |
| Siemens Medical Solutions USA, Inc. | 7 | $801 |
| Johnson & Johnson | 26 | $553 |
| Impulse Dynamics (USA) Inc. | 27 | $523 |
| Abbott | 13 | $491 |
| Novartis | 22 | $427 |
| Merck | 18 | $354 |
| E.r. Squibb & Sons, L.L.C. | 20 | $298 |
| Globus Medical | 5 | $211 |
| Boston Scientific | 2 | $194 |
| Penumbra, Inc. | 1 | $177 |
| Shockwave Medical, Inc | 1 | $174 |
| Tactile Systems Technology Inc | 3 | $164 |
| Terumo Medical Corporation | 2 | $149 |
| Pfizer | 9 | $148 |
| Amgen | 7 | $133 |
| Sanofi-aventis U.S. LLC | 7 | $107 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $89 |
| Heartflow, Inc. | 1 | $83 |
| Alnylam Pharmaceuticals Inc. | 4 | $80 |
| Novo Nordisk | 3 | $79 |
| Amarin Pharma, Inc. | 6 | $77 |
| Reflow Medical Inc | 2 | $67 |
| Biotronik Inc. | 1 | $66 |
| Medline Industries LP | 2 | $44 |
| Amryt Pharma Holdings Ltd | 2 | $41 |
| AstraZeneca | 3 | $36 |
| Avinger Inc. | 1 | $36 |
| Altathera Pharmaceuticals LLC | 2 | $30 |
| Kestra Medical Technology Services, Inc. | 1 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Preventice Services, LLC | 1 | $18 |
| GSK | 1 | $17 |
| Teleflex LLC | 1 | $16 |
| Itamar Medical Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$8,365
- SilverHawk$496
- Abre$287
- OPTIMIZER$234
- Trilogy 100$233
- AMPHIRION DEEP$229
- Penumbra System$177
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$174
- GENERAL - THERAPIES$173
- IN.PACT Admiral$169
- Varian CRYOCARE TOUCH System$160
- EMBOZENE$160
- Senza$140
- Admiral Xtreme$134
- Flexitouch Plus$134
- Entre Plus$134
- ANGIO-SEAL$115
- Resolute$106
- Assurity Pacemaker$100
How this compares
$18,840 in reported general payments places this provider in the 80th percentile of 80 vascular & interventional radiology providers in Arizona.
See all vascular & interventional radiology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 35 | $30,818 |
| XareltoRivaroxaban | 26 | $21,191 |
| ClopidogrelClopidogrel Bisulfate | 141 | $1,964 |
| Cilostazol | 15 | $409 |
| Furosemide | 14 | $115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $148 | $30,81835 claims |
| Johnson & JohnsonXarelto | $553 | $21,19126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 80 vascular & interventional radiology providers in Arizona.
Other vascular & interventional radiology in Mesa
- Isael PerezMesa$22K
- Karen GarbyMesa$6K
- Benjamin StradlingMesa$2K
- Rahmi OkluScottsdale$16.9M
- Shamar YoungTucson$285K
- Joel RainwaterGilbert$241K
- Christopher GoettlScottsdale$220K
- Kamalani HanamaikaiPhoenix$205K
- Merve OzenScottsdale$47K
- Arnold SahaScottsdale$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.